Terms: = Sarcomas AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
53 results:
1. A Case Study of a Rare Undifferentiated Spindle Cell Sarcoma of the Penis: Establishment and Characterization of Patient-Derived Models.
Sousa ACDS; Fernandes BLNC; da Silva JPA; Stevanato Filho PR; Coimbra LBCT; de Oliveira Beserra A; Alvarenga AL; Maida G; Guimaraes CT; Nakamuta IM; Marchi FA; Alves C; Lichtenfels M; de Farias CB; Kupper BEC; Costa FD; de Mello CAL; Carraro DM; Torrezan GT; Lopes A; Dos Santos TG
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674359
[TBL] [Abstract] [Full Text] [Related]
2. Conjunctival leiomyosarcoma: A clinico-pathological study with in deep molecular characterization.
Santoro A; Angelico G; Mulè A; Minucci A; Giannuzzi F; Sammarco MG; Pagliara MM; Blasi MA
Pathol Res Pract; 2024 Mar; 255():155182. PubMed ID: 38335782
[TBL] [Abstract] [Full Text] [Related]
3. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract] [Full Text] [Related]
5. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
6. A rare metastatic mesenteric malignant PEComa with tsc2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract] [Full Text] [Related]
7. A Clinicopathologic and Molecular Characterization of Uterine sarcomas Classified as Malignant PEComa.
Anderson WJ; Dong F; Fletcher CDM; Hirsch MS; Nucci MR
Am J Surg Pathol; 2023 May; 47(5):535-546. PubMed ID: 36856023
[TBL] [Abstract] [Full Text] [Related]
8. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and tsc2 ubiquitination.
Tsang SV; Rainusso N; Liu M; Nomura M; Patel TD; Nakahata K; Kim HR; Huang S; Rajapakshe K; Coarfa C; Man TK; Rao PH; Yustein JT
Oncogene; 2022 Dec; 41(50):5373-5384. PubMed ID: 36348010
[TBL] [Abstract] [Full Text] [Related]
10. Primary Cutaneous Malignant Perivascular Epithelioid Cell Tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity.
Neumann NM; Cornelia Ding CK; Borgen A; Corvera CU; North JP; Qorbani A; Horvai AE
Am J Dermatopathol; 2022 Oct; 44(10):768-773. PubMed ID: 36122336
[TBL] [Abstract] [Full Text] [Related]
11. Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.
Liu J; Gao T; Tan Z; Li S; Xu J; Bai C; Xue R; Xie L; Zhang L; Fan Z; Guo W
Clin Cancer Res; 2022 Aug; 28(16):3473-3479. PubMed ID: 35675031
[TBL] [Abstract] [Full Text] [Related]
12.
Wagner AJ; Ravi V; Riedel RF; Ganjoo K; Van Tine BA; Chugh R; Cranmer L; Gordon EM; Hornick JL; Du H; Grigorian B; Schmid AN; Hou S; Harris K; Kwiatkowski DJ; Desai NP; Dickson MA
J Clin Oncol; 2021 Nov; 39(33):3660-3670. PubMed ID: 34637337
[TBL] [Abstract] [Full Text] [Related]
13. tsc2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.
Chiang S; Vasudevaraja V; Serrano J; Stewart CJR; Oliva E; Momeni-Boroujeni A; Jungbluth AA; Da Cruz Paula A; da Silva EM; Weigelt B; Park KJ; Soslow RA; Murali R; Ellenson LH; Benayed R; Ladanyi M; Abu-Rustum NR; Dickson MA; Cohen S; Aghajanian C; Hensley ML; Lee CH; Snuderl M; Konner JA
Mod Pathol; 2022 Jan; 35(1):117-127. PubMed ID: 34561551
[TBL] [Abstract] [Full Text] [Related]
14. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract] [Full Text] [Related]
15. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour.
Caliò A; Brunelli M; Segala D; Zamboni G; Bonetti F; Pea M; Martignoni G
Pathology; 2021 Jan; 53(1):129-140. PubMed ID: 33131798
[TBL] [Abstract] [Full Text] [Related]
16. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
17. mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.
Triki M; Rinaldi G; Planque M; Broekaert D; Winkelkotte AM; Maier CR; Janaki Raman S; Vandekeere A; Van Elsen J; Orth MF; Grünewald TGP; Schulze A; Fendt SM
Cell Rep; 2020 Jun; 31(12):107806. PubMed ID: 32579932
[TBL] [Abstract] [Full Text] [Related]
18.
Pujadas E; Chen L; Weingart JD; Orr B; Ozer BH; Holdhoff M; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):179-187. PubMed ID: 32017698
[TBL] [Abstract] [Full Text] [Related]
19. Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.
Smolle MA; Schaffler A; Leithner A; Van Praag VM; Bergovec M; Szkandera J; Liegl-Atzwanger B; Niethard M; Tunn PU; Van De Sande M; Andreou D
J Surg Oncol; 2020 Mar; 121(4):605-611. PubMed ID: 32003475
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
Wang Z; Zheng C; Sun H; Yao W; Li K; Ma Y; Zheng S
Dermatology; 2020; 236(3):262-270. PubMed ID: 31896113
[TBL] [Abstract] [Full Text] [Related]
[Next]
